Login

Suzy Dilly, CEO, ValiRx 00:00:00

Share On Facebook Share On Twitter

Suzy Dilly, ValiRx CEO reiterates her support for TheoremRx and hails 'brilliant science' Cytolytix

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Peruvian Metals CEO Jeff Reader Announces Production and Plant Updates for 2024
00:10:00
Fred Wagenhals, CEO of AMMO Inc., on Innovative Ammunition, Gun Safety, and Business Growth | Fred Wagenhals, CEO, Ammo Inc.
00:10:00
Surplus Lines Market Sees Record Growth and Evolving Risks, Especially in Cyber Insurance
00:10:00
Generation Mining: Advancing Palladium Projects in Northern Canada
00:10:00
Investing 411: Expert Insights with Bernstein Global Wealth Management
00:10:00
led investment rounds for legal AI platform Harvey and online mental health platform Grow Therapy|Pat Grady,partner,Sequoia
00:10:00
Revolutionizing Healthcare Through Genetic Transparency and Choice|Anne Wojcicki, CEO, 23andme holding co.
00:00:00
Destiny Pharma's nasal spray project already delivering "more than hoped for" - Neil Clark , CEO, Destiny Pharma
00:10:00
Heinrich Miller Discusses Jangada Mines' PGM Project at One-to-One Investment Conference
00:10:00
Overview of TLC Lithium Project: Resource and Mining Details
00:10:00
Apella Wealth offers financial planning services, highlighted in an explainer video.|Patrick A. Sweeny is a founding partner of Apella Capital.
00:10:00
Navigating Challenges and Embracing Opportunities in the Financial Services Industry | Paul Desmarais Jr., CEO, Power Financial Corporation.

© 2026 Nehu